Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pharmaxis Ltd ( (AU:SNT) ) has shared an announcement.
Syntara Limited has announced the cessation of 452,430 performance rights due to the lapse of conditional rights that were not met or became incapable of being satisfied. This cessation could impact the company’s capital structure and may have implications for stakeholders, reflecting on the company’s ability to meet certain performance conditions.
More about Pharmaxis Ltd
YTD Price Performance: -7.50%
Average Trading Volume: 2,817,058
Technical Sentiment Signal: Hold
Current Market Cap: A$120.1M
See more insights into SNT stock on TipRanks’ Stock Analysis page.